Auston Cherbonneaux: Why Erythritol Just Joined the High-Hazard List
Auston Cherbonneaux, Science Communicator, Author, Publisher, shared a post on LinkedIn about an article by Marco Witkowski, published in Nature Medicine, adding:
“Ingredient Alert
Erythritol (common non caloric sweetener) has evidence to suggest it compromises the blood-brain barrier over time.
This one is a bit more complicated. Still, enough evidence to start taking extreme caution for populations vulnerable to stroke, cardiac events, and thrombosis.
First, a study of about 1000 people suggests that people who are in the upper quartile of erythritol in blood were twice as likely to suffer a major cardiac event compared to the first quartile.
The conclusion to the study referenced in the article [Abstract]:
‘Our findings reveal that erythritol is both associated with incident MACE risk and fosters enhanced thrombosis. Studies assessing the long-term safety of erythritol are warranted.’
Second, experimental finding to this point is only on cells in a petri dish, next step is “blood vessels on a chip” to better mimic physiology.
I don’t need a third.
This is going on the ‘habitual extreme hazard‘ list.”
Title: The artificial sweetener erythritol and cardiovascular event risk
Authors: Marco Witkowski, Ina Nemet, Hassan Alamri, Jennifer Wilcox, Nilaksh Gupta, Nisreen Nimer, Arash Haghikia, Xinmin S. Li, Yuping Wu, Prasenjit rasad Saha, Ilja Demuth, Maximilian König, Elisabeth Steinhagen-Thiessen, Tomas Cajka, Oliver Fiehn, Ulf Landmesser, W. H. Wilson Tang, Stanley L. Hazen
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape
-
Jun 26, 2026, 05:57Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk
-
Jun 26, 2026, 05:55Shinya Goto: How Newton’s Laws Shape Platelet Function
-
Jun 26, 2026, 05:50Andrew Emad: Five Years of Partnership, Innovation, and Impact at Africa Health ExCon 2026
-
Jun 26, 2026, 05:48Regan Bucciol: The Emerging Role of Erythrocytes in Thrombosis
-
Jun 26, 2026, 05:26Maxime Dely: Strengthening Skills in Plasma and Red Cell Exchange
-
Jun 26, 2026, 05:26Andreas Calatzis: Hidden Differences in Anti-Xa Testing